Shanghai Cell Therapy Group
PrivateLast Round
Series D
Dec 6, 2021
Est. Valuation
$1.12B
Total Funding Raised
$278.33M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Shanghai Cell Therapy Group is a biotechnology company that develops cell therapy products and provides related services for cancer and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Cell Therapy Group Comparables
Compare Shanghai Cell Therapy Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vcanbio Cell & Gene Engineering Corporation | 75% | |
| Shenzhen Beike Biotechnology Co., Ltd. | 66% | |
| JW Therapeutics | 59% | |
Shanghai Cell Therapy Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 6, 2021 | ||||
| Series D | Mar 23, 2021 | ||||
| Series C | Dec 17, 2018 | ||||
| Series B | Apr 19, 2016 | ||||
| Series A | Jun 3, 2014 |
Shanghai Cell Therapy Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GF Xinde Investment Management | Series D |
| Legend Capital | Series C, Series B |
| CCB International | Series D |
| 怀格资本 | Series D |
| Jiuzhou Venture | Series D |
| China Industrial Asset Management Limited | Series C |
| Haier Capital | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 28, 2.2x the trailing average.
- Jun 21, 2026
Monthly visitors grew 116% MoM.
Shanghai Cell Therapy Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Cell Therapy Group's valuation, stock price, and market status.